Professor joins pSiMedica
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Tuesday, 6 May, 2003 - 22:00
pSivida’s UK subsidiary pSiMedica has added to its team, appointing Texan professor Jeffrey Coffer as a collaborator. Professor Coffer’s professional background includes research into semiconductor nanocrystal synthesis, properties and characterization, with particular reference to porous silicon. pSivida, a local listed nanotechnology company, is developing porous silicon medical applications in drug delivery and orthopaedics for its trademarked product BioSilicon.
Professor Coffer has focused his most recent research in BioSilicon™ in the fields of orthopaedics and tissue engineering, as well as researching silicon nanowires and rare earth incorporation into porous silicon for optoelectrical and biomedical applications.